Async Telehealth

Async (asynchronous) telehealth is the dominant operating model for many direct-to-consumer telehealth platforms. The patient completes a structured intake form, may upload photos or lab results, and submits the encounter. A licensed clinician reviews the information, makes a clinical determination, and either prescribes, requests additional information, or declines to prescribe.

This model contrasts with synchronous telehealth (real-time video or phone consultation) and with traditional in-person care.

Most U.S. states permit async prescribing under specific conditions. Common requirements include:

- The clinician must be licensed in the state where the patient is physically located at the time of care. - A bona fide clinician-patient relationship must be established. - The clinical encounter must include an appropriate evaluation for the medication being prescribed. - Some controlled substances may require synchronous evaluation under federal or state rules.

The async model is well-suited to medications where the clinical evaluation is largely structured (intake-form based) and the medication has well-characterized risk profile. Hair loss, ED, and chronic acne are commonly managed through async pathways.

Async telehealth is less appropriate for clinical scenarios requiring physical examination, real-time clinical reasoning, or extensive patient education. Some platforms blend async intake with synchronous consultation for higher-acuity cases.

State-level regulation evolves. The legal status of async prescribing for any specific medication should be verified by the platform, the prescriber, and ideally the patient.